Status:
COMPLETED
Long-term Evaluation of Single-piece ACrysof IOL Implantation on Development of Posterior Capsule Opacification
Lead Sponsor:
Iladevi Cataract and IOL Research Center
Conditions:
Posterior Capsule Opacification After Phacoemulsification and IOL Implantation
Eligibility:
All Genders
40-75 years
Brief Summary
Although contemporary cataract surgery has made tremendous strides in technological advancement, posterior capsular opacification (PCO) is still the most frequent long-term complication leading to dec...
Eligibility Criteria
Inclusion
- patients with uncomplicated age-related cataract who were otherwise healthy
Exclusion
- a history of diabetes mellitus (DM),
- patients with glaucoma,
- high myopia (axial length \> 27.0 mm),
- pseudoexfoliation,
- traumatic cataract,
- subluxated cataract,
- previous ocular surgeries, and
- allergy to dilating drops.
Key Trial Info
Start Date :
June 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2011
Estimated Enrollment :
390 Patients enrolled
Trial Details
Trial ID
NCT01820065
Start Date
June 1 2005
End Date
October 1 2011
Last Update
March 28 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Iladevi Cataract & IOL Research Centre
Ahmedabad, Gujarat, India, 380052